Current Challenges in Glia-Pain Biology

Neuron

Volumn 64, Issue 1, 2009, Pages 46-54

  McMahon, Stephen B ^a   Malcangio, Marzia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE; GLUTAMIC ACID; SUBSTANCE P;

ASTROCYTE; CELL ACTIVATION; CELL FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CYTOKINE PRODUCTION; GLIA CELL; HUMAN; MICROGLIA; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PAIN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BRAIN; CHRONIC DISEASE; HUMANS; MODELS, NEUROLOGICAL; NEUROGLIA; PAIN; SPINAL CORD;

EID: 70349984436     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.09.033     Document Type: Review

References (83)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., and Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA 100 (2003) 7947-7952
2. Abbadie C., Bhangoo S., De Koninck Y., Malcangio M., Melik-Parsadaniantz S., and White F.A. Chemokines and pain mechanisms. Brain Res. Rev. 60 (2009) 125-134
3. Ajami B., Bennett J.L., Krieger C., Tetzlaff W., and Rossi F.M.V. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10 (2007) 1538-1543
4. Alexander G.M., van Rijn M.A., van Hilten J.J., Perreault M.J., and Schwartzman R.J. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116 (2005) 213-219
5. Banati R.B., Cagnin A., Brooks D.J., Gunn R.N., Myers R., Jones T., Birch R., and Anand P. Long-term trans-synaptic gial responses in the human thalamus after peripheral nerve injury. Neuroreport 12 (2001) 3439-3442
6. Beggs S., and Salter M.W. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Behav. Immun. 21 (2007) 624-633
7. Brooks T.A., Ocheltree S.M., Seelbach M.J., Charles R.A., Nametz N., Egleton R.D., and Davies T.P. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res. 1120 (2006) 172-182
8. Cardona A.E., Li M., Liu L., Savarin C., and Ransohoff R.M. Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 84 (2008) 587-594
9. Carson M.J., Doose J.M., Melchior B., Schmid C.D., and Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213 (2006) 48-65
10. Cata J.P., Weng H.R., and Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res. 1229 (2008) 100-110
11. Clark A.K., D'Aquisto F., Gentry C., Marchand F., McMahon S.B., and Malcangio M. Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J. Neurochem. 99 (2006) 868-880
12. Clark A.K., Yip P., Grist J., Gentry C., Staniland A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., et al. Inhibition of spinal microglial cathepsin S for the reversal of the neuropathic pain. Proc. Natl. Acad. Sci. USA 104 (2007) 10655-10660
13. Clark A.K., Gentry C., Bradbury E., McMahon S.B., and Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain 11 (2007) 223-230
14. Clark A.K., Yip P.K., and Malcangio M. The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S. J. Neurosci. 29 (2009) 6945-6954
15. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., and De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 (2005) 1017-1021
16. Day M. Sympathetic blocks: the evidence. Pain Pract. 8 (2008) 98-109
17. Del Valle L., Schwartzman R.J., and Alexander G. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain Behav. Immun. 23 (2009) 85-91
18. Echeverry S., Shi X.Q., and Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 135 (2008) 37-47
19. Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., and Ji R.R. JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic Pain. J. Neurosci. 29 (2009) 4096-4108
20. Getts D.R., Terry R.L., Getts M.T., Muller M., Rana S., Shrestha B., Radford J., van Rooijen N., Campbell I.L., and King N.J.C. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205 (2008) 2319-2337
21. Gordh T., Chu H., and Sharma H.S. Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 124 (2006) 211-221
22. Griffin R.S., Costigan M., Brenner G.J., Him Eddie Ma C., Scholz J., Moss A., Allchorne A.J., Stahl G.L., and Woolf C.J. Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity. J. Neurosci. 27 (2007) 8699-8708
23. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., Wei F., Dubner R., and Ren K. Glial-Cytokine-Neuronal Interactions Underlying the Mechanisms of Persistent Pain. J. Neurosci. 27 (2007) 6006-6018
24. Hains B.C., and Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26 (2006) 4308-4317
25. Hald A., Ding M., Egerod K., Hansen R.R., Konradsen D., Jorgensen S.G., Atalay B., Nasser A., Bjerrum O.J., and Heegaard A.M. Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Pharmacol. Biochem. Behav. 91 (2008) 38-46
26. Haydon P.G. GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2 (2001) 185-193
27. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., and Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9 (2006) 1512-1519
28. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., and Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur. J. Neurosci. 22 (2005) 2431-2440
29. 7 in pain and inflammation. Purinergic Signal. 3 (2007) 163-169
30. Inoue K., and Tsuda M. Microglia and neuropathic pain. Glia (2009) 10.1002/glia.20871 in press. Published online March 20, 2009
31. Irie O., Kosaka T., Ehara T., Yokokawa F., Kanazawa T., Hirao H., Iwasaki A., Sakaki J., Teno N., Hitomi Y., et al. Discovery of selective and non peptidic cathepsin S inhibitors. J. Med. Chem. 51 (2008) 5502-5505
32. Ji R.R., and Suter M. p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 3 (2007) 33-42
33. Ji R.-R., Kawasaki Y., Zhuang Z.-Y., Wen Y.-R., and Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2 (2006) 259-269
34. Katz N., Borenstein D., Birbara C., Bramson C., Nemeth M., Smith M., and Brown M. Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) - a randomized, controlled, double-blind, phase 2 trial. J. Pain 10 suppl 1 (2009) S42
35. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., and Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 14 (2008) 331-336
36. Lai A.Y., and Todd K.G. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia 53 (2006) 809-816
37. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., and Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
38. Levin M.E., Jin J.G., Ji R.R., Tong J., Pomonis J.D., Lavery D.J., Miller S.W., and Chiang L.W. Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain. Pain 137 (2008) 182-201
39. 2+ increases in microglia. Neuron Glia Biol. 2 (2006) 125-138
40. Liu L., Tornqvist E., Mattsson P., Eriksson N.P., Persson J.K.E., Morgan B.P., Aldskogius H., and Svensson M. Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat. Neuroscience 68 (1995) 167-179
41. Liu L., Rudin M., and Kozlova E.N. Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp. Brain Res. 131 (2000) 64-73
42. Melzack R. The future of pain. Nat. Drug Discov. 7 (2009) 629
43. Milligan E.D., and Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10 (2009) 23-36
44. Moran L.B., and Graeber M.B. The facial nerve axotomy model. Brain Res. Brain Res. Rev. 44 (2004) 154-178
45. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science 308 (2005) 1314-1318
46. Palma C., Minghetti L., Astolfi M., Ambrosini E., Ceccherini Silberstein F., Manzini S., Levi G., and Aloisi F. Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production. Glia 21 (1997) 183-193
47. Peters C.M., Jimenez-Andrade J.M., Kuskowski M.A., Ghilardi J.R., and Mantyh P.W. An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res. 1168 (2007) 46-59
48. Pezet S., Malcangio M., and McMahon S.B. BDNF: a neuromodulator in nociceptive pathways?. Brain Res. Brain Res. Rev. 40 (2002) 240-249
49. Polgar E., Hughes D.I., Arham A.Z., and Todd A.J. Loss of Neurons from Laminas I-III of the Spinal Dorsal Horn Is Not Required for Development of Tactile Allodynia in the Spared Nerve Injury Model of Neuropathic Pain. J. Neurosci. 25 (2005) 6658-6666
50. Raghavendra V., Tanga F.Y., and Deleo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20 (2004) 467-473
51. Ransohoff R.M., and Perry V.H. Microglial Physiology: Unique Stimuli, Specialized Responses. Annu. Rev. Immunol. 27 (2009) 119-145
52. Rasley A., Bost K.L., Olson J.K., Miller S.D., and Marriott I. Expression of functional NK-1 receptors in murine microglia. Glia 37 (2002) 258-267
53. Romero-Sandoval A., Chai N., Nutile-McMenemy N., and DeLeo J.A. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res. 1219 (2008) 116-126
54. Romero-Sandoval E.A., Horvath R.J., and Deleo J.A. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr. Opin. Investig. Drugs 9 (2008) 726-734
55. Rossi D.J., Brady J.D., and Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10 (2007) 1377-1386
56. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10 (2007) 1361-1368
57. Sievers J., Parwaresch R., and Wottge H.U. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: morphology. Glia 12 (1994) 245-258
58. Sorkin L.S., Boyle D., Hammaker D., Herman D., Vail E., and Firestein G.S. MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice. Neuroscience 162 (2009) 462-471
59. Sun S., Cao H., Han M., Li T.T., Pan H.L., Zhao Z.Q., and Zhang Y.Q. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis. Pain 129 (2007) 64-75
60. Svensson C.I., Marsala M., Westerlund A., Calcutt N.A., Campana W.M., Freshwater J.D., Catalano R., Feng Y., Protter A.A., Scott B., and Yaksh T.L. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J. Neurochem. 86 (2003) 1534-1544
61. Svensson C.I., Zattoni M., and Serhan C.N. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J. Exp. Med. 204 (2007) 245-252
62. Sweitzer S.M., Pahl J.L., and Deleo J.A. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat. Neurosci. Lett. 400 (2006) 258-261
63. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., et al. Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1. Science 276 (1997) 1699-1702
64. Tanga F.Y., Raghavendra V., and Deleo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int. 45 (2004) 397-407
65. Tanga F.Y., Nutile-McMenemy N., and Deleo J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA 102 (2005) 5856-5861
66. Tawfik V.L., Nutile-McMenemy N., Lacroix-Fralish M.L., and DeLeo J.A. Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Brain Behav. Immun. 21 (2007) 238-246
67. Tawfik V.L., Regan M.R., Haenggeli C., LaCroix-Fralish M.L., Nutile-McMenemy N., Perez N., Rothstein J.D., and Deleo J.A. Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 152 (2008) 1086-1092
68. Terayama R., Omura S., Fujisawa N., Yamaai T., Ichikawa H., and Sugimoto T. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 153 (2008) 1245-1255
69. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D.F., Thompson S.W.N., Marchand F., and McMahon S.B. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 13 (2009) 263-272
70. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., and Inoue K. P2Y12 Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury. J. Neurosci. 28 (2008) 4949-4956
71. Tracey I. Neuroimaging of pain mechanisms. Curr. Opin. Support. Palliat. Care 1 (2007) 109-116
72. Trang T., Beggs S., Wan X., and Salter M.W. P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation. J. Neurosci. 29 (2009) 3518-3528
73. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
74. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
75. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., and Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28 (2008) 11263-11268
76. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20 (2004) 1150-1160
77. Wei F., Guo W., Zou S., Ren K., and Dubner R. Supraspinal Glial-Neuronal Interactions Contribute to Descending Pain Facilitation. J. Neurosci. 28 (2008) 10482-10495
78. Wodarski R., Clark A.K., Grist J., Marchand F., and Malcangio M. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur. J. Pain 13 (2009) 807-811
79. Wu L.J., and Zhuo M. Resting microglial motility is independent of synaptic plasitcity in mammalian brain. J. Neurophysiol. 99 (2008) 2026-2032
80. Zhang J., and De Koninck Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J. Neurochem. 97 (2006) 772-783
81. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., and Rivest S. Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain. J. Neurosci. 27 (2007) 12396-12406
82. Zhang F., Vadakkan K., Kim S., Wu L.J., Shang Y., and Zhuo M. Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol. Pain 4 (2008) 15
83. Zhao P., Waxman S.G., and Hains B.C. Modulation of Thalamic Nociceptive Processing after Spinal Cord Injury through Remote Activation of Thalamic Microglia by Cysteine Cysteine Chemokine Ligand 21. J. Neurosci. 27 (2007) 8893-8902